Biopsychosocial approach in cardiological care: a scoping review of integrated treatments for personalized patient care

心脏病护理中的生物心理社会模式:个性化患者护理综合治疗的范围界定综述

阅读:1

Abstract

OBJECTIVE: We conducted a scoping review of the literature focusing on combining biomarker detection and psychological evaluation according to the biopsychosocial approach to expound the multifactorial aspects of cardiological care. METHOD: The search strategy was restricted to the 2014-2024 period. The core of this evidence-based analysis was the investigation of emotional and behavioural signs in cardiovascular (CV) risk/disease, the characteristics of adherence, and the efficacy of psychological treatments, especially highlighting the evidence of studies based on pre-post study design models for the investigation of psychological treatment efficacy in CV risk/disease. RESULTS: The literature includes systematic reviews and meta-analyses on patient education for the effectiveness of psychological interventions on psychosocial aspects and, consequently, on adherence to therapeutic prescriptions. From this perspective, it is important to adopt the biopsychosocial approach in the prevention, evaluation, and management of CV disease to understand all determinants of disease and multidisciplinary treatments. Topics are arranged into six themes: (1) epidemiological aspects of the included studies, (2) medical and psychological insights into CV research protocols from an integrated biopsychological perspective, (3) evidence of emotional and behavioural symptoms in CV risk, (4) evidence of emotional and behavioural symptoms in CV disease, (5) characteristics of adherence and psychological treatment, and (6) evidence of pre- and post-psychological treatment in CV risk/disease. CONCLUSIONS: This review demonstrates that interventions are required to address patient factors, such as emotional, behavioural, and cognitive dimensions, that can improve the quality of life and adherence to medication. The link between physical and mental care is crucial and should be supported by extensive evidence-based outcomes in terms of tailored actions in health monitoring and management of CV risk/disease clinical targets.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。